The role of leukotrienes in allergic rhinitis

This publication has 71 references indexed in Scilit:

• Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2004
• Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast
  Annals of Allergy, Asthma & Immunology, 2003
• Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2003
• Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall
  Annals of Allergy, Asthma & Immunology, 2002
• The Murine Cysteinyl Leukotriene 2 (CysLT2) Receptor
  Published by Elsevier ,2001
• Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis
  Annals of Allergy, Asthma & Immunology, 2001
• Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure
  Annals of Allergy, Asthma & Immunology, 2001
• Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”
  Annals of Allergy, Asthma & Immunology, 2000
• Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
  Annals of Allergy, Asthma & Immunology, 1998
• Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed
  New England Journal of Medicine, 1984